更正：用于检测BRCA1突变携带者中卵巢癌的诊断标志物。
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
作者信息
Gschwantler-Kaulich Daphne, Weingartshofer Sigrid, Rappaport-Fürhauser Christine, Zeillinger Robert, Pils Dietmar, Muhr Daniela, Braicu Elena I, Kastner Marie-Therese, Tan Yen Y, Semmler Lorenz, Sehouli Jalid, Singer Christian F
出版信息
PLoS One. 2018 Apr 17;13(4):e0196142. doi: 10.1371/journal.pone.0196142. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0189641.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0189641。]
相似文献
1
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.更正：用于检测BRCA1突变携带者中卵巢癌的诊断标志物。
PLoS One. 2018 Apr 17;13(4):e0196142. doi: 10.1371/journal.pone.0196142. eCollection 2018.
2
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.用于检测BRCA1突变携带者卵巢癌的诊断标志物。
PLoS One. 2017 Dec 15;12(12):e0189641. doi: 10.1371/journal.pone.0189641. eCollection 2017.
3
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.BRCA1或BRCA2基因突变携带者患卵巢癌的生殖风险因素：一项病例对照研究。
Lancet Oncol. 2007 Jan;8(1):26-34. doi: 10.1016/S1470-2045(06)70983-4.
4
Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.口服避孕药与 BRCA 基因突变携带者卵巢癌和乳腺癌风险的关系：一项荟萃分析。
Expert Rev Anticancer Ther. 2011 Aug;11(8):1197-207. doi: 10.1586/era.11.38.
5
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.RAD51基因5'非翻译区的单核苷酸多态性与BRCA1/2突变携带者的癌症风险
Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.
6
Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.携带BRCA1/2基因突变的犹太裔以色列女性雄激素受体CAG重复序列长度：与乳腺癌/卵巢癌表型的关联
Eur J Hum Genet. 2002 Nov;10(11):724-8. doi: 10.1038/sj.ejhg.5200880.
7
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.BRCA1 和 BRCA2 家族乳腺癌、卵巢癌和对侧乳腺癌的外显率：老年时癌症发病率高。
Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4.
8
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.X染色体失活偏倚与乳腺癌和卵巢癌状态：BRCA1的X连锁修饰因子的证据
J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.
9
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌和卵巢癌发病风险与生育情况相关。
Breast Cancer Res Treat. 2010 Jan;119(1):221-32. doi: 10.1007/s10549-009-0394-1. Epub 2009 Apr 16.
10
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.年轻健康的BRCA1基因突变携带者卵泡期促黄体生成素水平升高：对乳腺癌和卵巢癌风险的影响。
Mol Genet Metab. 2005 Sep-Oct;86(1-2):320-7. doi: 10.1016/j.ymgme.2005.06.007. Epub 2005 Aug 3.
引用本文的文献
1
Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.与BRCA1/2携带者中较高卵巢癌风险相关的血浆蛋白生物标志物。
Cancers (Basel). 2021 May 11;13(10):2300. doi: 10.3390/cancers13102300.
本文引用的文献
1
Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.用于检测BRCA1突变携带者卵巢癌的诊断标志物。
PLoS One. 2017 Dec 15;12(12):e0189641. doi: 10.1371/journal.pone.0189641. eCollection 2017.
Zotero 插件